Axsome Therapeutics, Inc. (AXSM) key performance indicators and operating metrics (7 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| AUVELITY Payer Coverage All Lives Across Channels | 86.00 percent | FY2026-Q1 |
| AUVELITY Prescriptions Written | 223K | FY2026-Q1 |
| SUNOSI Payer Coverage All Channels | 83.00 percent | FY2026-Q1 |
| SUNOSI Prescriptions Written | 54K | FY2026-Q1 |
| SYMBRAVO Payer Coverage All Channels | 57.00 percent | FY2026-Q1 |
| SYMBRAVO Prescriptions Written | 17K | FY2026-Q1 |
| Debt Face Value | 190M | FY2025-Q3 |
Back to AXSM overview · AXSM earnings · AXSM holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.